2 results
Approved WMOCompleted
To assess the short-term efficacy of stellate ganglion block on hot flush reduction versus sham procedure
Approved WMORecruiting
The hypothesis is that the amivantamab and lazertinib combination (Arm A) will demonstrate superior PFS compared with single-agent osimertinib (Arm B).